Skip to main content

Advertisement

Log in

Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study was to investigate if antibody to cyclic citrullinated peptide (anti-CCP) is detected in sera of patients with chronic hepatitis B virus (HBV) infection. Serum anti-CCP and IgA, IgG, and IgM rheumatoid factor (RF) isotypes were measured by enzyme-linked immunosorbent assay on 176 non-arthritic patients with HBV infection. IgA RF, IgG RF, and IgM RF were detectable in 29.5, 21, and 18.8% of the tested sera, respectively, with a total seropositivity rate of 42.7%. Marginally elevated anti-CCP was detected in one patient (0.6%). By regression analysis, there was no statistically significant association between the serum levels of anti-CCP and serum IgA, IgG, or IgM RF (R 2 = 0.033, with respective p values of 0.224, 0.297, and 0.334). In conclusion, anti-CCP was rarely detected in non-arthritic patients with HBV infection in contrast to RF. Thus, testing for anti-CCP may be a useful tool for the diagnosis of rheumatoid arthritis in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lovy MR, Starkebaum G, Uberoi S (1996) Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 23:979–983

    PubMed  CAS  Google Scholar 

  2. Buskila D (2000) Hepatitis C-associated arthritis. Curr Opin Rheumatol 12:295–299

    Article  PubMed  CAS  Google Scholar 

  3. Pease C, Keat A (1985) Arthritis as the main symptom of hepatitis B infection. Postgrad Med J 61:545–547

    Article  PubMed  CAS  Google Scholar 

  4. Willson RA (1997) Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 92:3–17

    PubMed  CAS  Google Scholar 

  5. Csepregi A, Nemesanszky E, Rojkovich B, Poor G (2001) Rheumatoid arthritis and hepatitis B virus: evaluating the pathogenic link. J Rheumatol 28:474–477

    PubMed  CAS  Google Scholar 

  6. Watanabe K, Ohkubo Y, Funahashi Y et al (1991) An investigation on rheumatoid factor of different immunoglobulin classes in hepatitis B virus carriers. Clin Rheumatol 10:31–37

    Article  PubMed  CAS  Google Scholar 

  7. Schur PH, Shmerling RH (2003) Laboratory tests in rheumatic disorders. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology 3rd edn. Mosby, New York, pp 199–213

    Google Scholar 

  8. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA (2002) Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) 41:809–814

    Article  CAS  Google Scholar 

  9. Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079–1084

    Article  PubMed  CAS  Google Scholar 

  10. Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62:870–874

    Article  PubMed  CAS  Google Scholar 

  11. Sauerland U, Becker H, Seidel M et al (2005) Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci 1050:314–318

    Article  PubMed  CAS  Google Scholar 

  12. Lienesch D, Morris R, Metzger A, Debuys P, Sherman K (2005) Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. J Rheumatol 32:489–493

    PubMed  Google Scholar 

  13. Wener MH, Hutchinson K, Morishima C, Gretch DR (2004) Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 50:2305–2308

    Article  PubMed  CAS  Google Scholar 

  14. Bombardieri M, Alessandri C, Labbadia G et al (2004) Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 6:R137–141

    Article  PubMed  CAS  Google Scholar 

  15. Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337:1733–1745

    Article  PubMed  CAS  Google Scholar 

  16. Csepregi A, Rojkovich B, Nemesanszky E, Poor G, Hejjas M, Horanyi M (2000) Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: a sequel of virus persistence. Arthritis Rheum 43:232–233

    Article  PubMed  CAS  Google Scholar 

  17. Scully LJ, Karayiannis P, Thomas HC (1992) Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis. Dig Dis Sci 37:1757–1760

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong Gon Cho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, Si., Yoo, W.H., Yun, H.J. et al. Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection. Clin Rheumatol 26, 1079–1082 (2007). https://doi.org/10.1007/s10067-006-0451-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0451-7

Keywords

Navigation